Skip to main content
XRAY
NASDAQ Industrial Applications And Services

Dentsply Sirona Appoints Donald Zurbay to Board, Forms Growth & Value Creation Committee

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
7
Price
$12.55
Mkt Cap
$2.494B
52W Low
$9.85
52W High
$20.595
Market data snapshot near publication time

summarizeSummary

Dentsply Sirona appointed Donald J. Zurbay, a former CEO of Patterson Companies, to its Board of Directors and formed a new Growth and Value Creation Committee to support its 'Return-to-Growth action plan.'


check_boxKey Events

  • New Director Appointed

    Donald J. Zurbay was appointed to the Board of Directors, effective January 10, 2026. He will serve on the Audit and Finance Committee.

  • Experienced Industry Leader Joins Board

    Mr. Zurbay brings over 30 years of finance and accounting experience, including serving as President and CEO of Patterson Companies and CFO of St. Jude Medical, providing deep familiarity with the dental and healthcare sectors.

  • Board Size Increased

    The Board of Directors increased its size from 10 to 11 members with Mr. Zurbay's appointment.

  • New Growth and Value Creation Committee Formed

    The Board established a special four-member Growth and Value Creation Committee, co-chaired by the Chairman and CEO, to oversee the company's 'Return-to-Growth action plan.'


auto_awesomeAnalysis

Dentsply Sirona has appointed Donald J. Zurbay, a seasoned executive with extensive experience in the dental and healthcare industries, to its Board of Directors. Mr. Zurbay's background, including CEO and CFO roles at Patterson Companies and CFO at St. Jude Medical, brings valuable expertise in capital allocation and growth execution. Concurrently, the Board established a new Growth and Value Creation Committee, co-chaired by the CEO and Chairman, to oversee and support the company's 'Return-to-Growth action plan.' These actions signal a proactive and focused effort by the company to enhance strategic oversight and drive performance.

At the time of this filing, XRAY was trading at $12.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $9.85 to $20.60. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed XRAY - Latest Insights

XRAY
Apr 23, 2026, 4:32 PM EDT
Filing Type: DEF 14A
Importance Score:
8
XRAY
Mar 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
XRAY
Mar 03, 2026, 7:12 PM EST
Filing Type: 4
Importance Score:
7
XRAY
Feb 26, 2026, 5:58 PM EST
Source: Dow Jones Newswires
Importance Score:
8
XRAY
Feb 26, 2026, 5:06 PM EST
Source: dpa-AFX
Importance Score:
8
XRAY
Feb 26, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
8
XRAY
Feb 26, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
XRAY
Feb 24, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
7
XRAY
Jan 14, 2026, 7:55 AM EST
Filing Type: 8-K
Importance Score:
7
XRAY
Jan 13, 2026, 7:55 AM EST
Filing Type: 8-K
Importance Score:
7